{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:45:40Z","timestamp":1760647540036},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,19]]},"DOI":"10.7759\/cureus.20515","type":"journal-article","created":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T16:32:43Z","timestamp":1639931563000},"source":"Crossref","is-referenced-by-count":5,"title":["Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease"],"prefix":"10.7759","author":[{"given":"Nijin","family":"Jose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasant","family":"P.K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran G","family":"Kulirankal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo RA","year":"1991","unstructured":"DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991, 14:173-194. 10.2337\/diacare.14.3.173","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.08.061","article-title":"Adiponectin and cardiovascular disease: response to therapeutic interventions","volume":"49","author":"Han SH","year":"2007","unstructured":"Han SH, Quon MJ, Kim JA, Koh KK. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol. 2007, 49:531-538. 10.1016\/j.jacc.2006.08.061","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.06.082","article-title":"Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions","volume":"46","author":"Koh KK","year":"2005","unstructured":"Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol. 2005, 46:1978-1985. 10.1016\/j.jacc.2005.06.082","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.5.699","article-title":"The metabolically obese, normal-weight individual revisited","volume":"47","author":"Ruderman N","year":"1998","unstructured":"Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes. 1998, 47:699-713. 10.2337\/diabetes.47.5.699","journal-title":"Diabetes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women","volume":"107","author":"Ridker PM","year":"2003","unstructured":"Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003, 107:391-397. 10.1161\/01.cir.0000055014.62083.05","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan AD","year":"2001","unstructured":"Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001, 286:327-334. 10.1001\/jama.286.3.327","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2003.11.003","article-title":"Prevalence of metabolic syndrome in an Indian urban population","volume":"97","author":"Gupta R","year":"2004","unstructured":"Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol. 2004, 97:257-261. 10.1016\/j.ijcard.2003.11.003","journal-title":"Int J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.3.249","article-title":"The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians","volume":"164","author":"Manson JE","year":"2004","unstructured":"Manson JE, Skerrett PJ, Greenland P, VanItallie TB. The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med. 2004, 164:249-258. 10.1001\/archinte.164.3.249","journal-title":"Arch Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.4.427","article-title":"The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"163","author":"Park YW","year":"2003","unstructured":"Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003, 163:427-436. 10.1001\/archinte.163.4.427","journal-title":"Arch Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.10.3120","article-title":"Components of the \"metabolic syndrome\" and incidence of type 2 diabetes","volume":"51","author":"Hanson RL","year":"2002","unstructured":"Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the \"metabolic syndrome\" and incidence of type 2 diabetes. Diabetes. 2002, 51:3120-3127. 10.2337\/diabetes.51.10.3120","journal-title":"Diabetes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000080897.52664.94","article-title":"Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study","volume":"108","author":"Sattar N","year":"2003","unstructured":"Sattar N, Gaw A, Scherbakova O, et al.. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003, 108:414-419. 10.1161\/01.CIR.0000080897.52664.94","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.5.5661","article-title":"Liver pathology and the metabolic syndrome X in severe obesity","volume":"84","author":"Marceau P","year":"1999","unstructured":"Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 1999, 84:1513-1517. 10.1210\/jcem.84.5.5661","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31922-2","article-title":"Prevalence of non-alcoholic fatty liver disease: population based study","volume":"6","author":"Amarapurkar D","year":"2007","unstructured":"Amarapurkar D, Kamani P, Patel N, et al.. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007, 6:161-163. 10.1016\/S1665-2681(19)31922-2","journal-title":"Ann Hepatol"},{"key":"ref14","article-title":"A study of endothelial dysfunction in patients of non-alcoholic fatty liver disease","volume":"65","author":"Shukla V","year":"2017","unstructured":"Shukla V, Fatima J, Chaudhary S, Ali M, Mishra I. A study of endothelial dysfunction in patients of non-alcoholic fatty liver disease. J Assoc Physicians India. 2017, 65:18-22.","journal-title":"J Assoc Physicians India"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12554","article-title":"Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: a meta-analysis","volume":"46","author":"Fan Y","year":"2016","unstructured":"Fan Y, Wei F, Zhou Y, Zhang H. Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: a meta-analysis. Hepatol Res. 2016, 46:E165-173. 10.1111\/hepr.12554","journal-title":"Hepatol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/56886-study-of-endothelial-dysfunction-in-patients-with-non-alcoholic-fatty-liver-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:39Z","timestamp":1707507279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/56886-study-of-endothelial-dysfunction-in-patients-with-non-alcoholic-fatty-liver-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,19]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.20515","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,19]]}}}